Stavros G. Vizirgianakis - Aug 8, 2024 Form 4 Insider Report for Apyx Medical Corp (APYX)

Role
Director
Signature
/s/ Stavros G. Vizirgianakis
Stock symbol
APYX
Transactions as of
Aug 8, 2024
Transactions value $
$0
Form type
4
Date filed
8/12/2024, 04:50 PM
Previous filing
May 9, 2024
Next filing
Aug 19, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APYX Stock Option (Option to Buy) Award $0 -17K -50% $0.00 17K Aug 8, 2024 Common Stock 17K $1.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issued pursuant to the Issuer's Director Compensation Program as set forth in the Issuer's definitive proxy statement filed with the U.S. Securities and Exchange Commission on June 25, 2024, which provides for the issuance of a stock option to non-employee directors on the date of the Issuer's Annual Meeting of Stockholders. The option vests ratably over a 12-month period and becomes fully vested and exercisable on the first anniversary of the date of grant.